Lonza, Metagenics Sign Agreement
September 15, 2003
Lonza, Metagenics Sign Agreement
FAIR LAWN, N.J.Lonza Inc. selected San Clemente, Calif.-based Metagenics as its exclusive health care professional marketing partner for Lonzas PepZin GI ingredient. Metagenics will use the ingredient in its Zinlori 75 dietary supplement to support gastric health and relieve dyspeptic symptoms. This is the second of several supply channel agreements in Lonzas move to bring PepZin GI to Europe and North America. Lonza has an exclusive distribution agreement with Hamari Chemicals, the manufacturer of PepZin GI, for those markets.
Metagenics earnest commitment to evidence-based bioactive ingredients, their impressive sales force and brand equity among doctors made the partnership a natural selection, said Dan Murray, associate director of technical development for nutrition at Lonza. We are very excited to have Metagenics pharma-caliber field representatives disseminate the evidence and IP package on PepZin GI, and foster adoption within the integrative health care sector.
For more information, visit www.lonza.com or Booth #1406-1410 at SupplySide West.
You May Also Like